表紙
市場調査レポート

中国の肥満治療薬市場

Anti-Obesity Drugs Markets in China

発行 Asia Market Information & Development 商品コード 86346
出版日 ページ情報 英文 211 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
中国の肥満治療薬市場 Anti-Obesity Drugs Markets in China
出版日: 2016年05月01日 ページ情報: 英文 211 Pages
概要

当レポートでは、中国の経済動向、肥満治療薬市場の投資環境、産業の発展、需要および供給、産業構造、市場チャネルおよび主要企業などについて詳細に調査し、実績および長期予測を提供しています。

第1章 イントロダクション

  • 本調査書の範囲と方法論
  • エグゼクティブサマリー

第2章 ビジネス環境

  • 経済展望
    • 主な経済指標
    • 工業生産高
    • 人口および労働力
    • 海外からの投資
    • 海外貿易
  • 金融および税金の規制
    • 銀行制度および規制
    • 外国為替
    • 税金、関税および税関

第3章 肥満治療薬産業アセスメント

  • 産業構造
    • 市場規模
    • 市場成長促進要因
    • 産業のキャパシティ
    • 主要メーカーの設備拠点および生産高
  • 主要メーカーの市場シェア
  • 労働コスト
    • 潜在性のある参入企業
    • 主な流通企業
  • 主な海外からの投資
  • 技術開発

第4章 肥満治療薬の生産および需要

  • 概要
    • 地域別需要
    • 生産高および需要
  • Sibutramine
    • 主なメーカー
    • 需給
  • 漢方薬
    • 主なメーカー
    • 需給
  • Orlistat
    • 主なメーカー
    • 需給
  • Rimonabant
    • 主なメーカー
    • 需給
  • Metformin
    • 主なメーカー
    • 需給
  • その他の肥満治療薬
  • 輸出入
    • 輸入
    • 輸出
  • 価格の動向

第5章 肥満治療薬の市場展望

  • 市場の展望
  • 政府の規制
  • 医療保険産業の概要
  • 消費者支出の動向
  • 人口動向
  • 医療産業の動向
  • 病院および病床
  • 医師および往診

第6章 市場戦略

  • 中国市場参入の概要
    • 流通システム
    • 肥満治療薬の流通チャネル
    • 運輸および輸送インフラ
    • 通信
  • 中国市場への参入
    • 対中国輸出
    • 間接輸出
    • 直接輸出
    • ライセンスおよび提携製造
    • 中国内組み立て
    • 提携製造
    • 貿易許可
    • 投資
    • 資本提携
    • 共同提携
    • 完全外資企業

第7章 肥満治療薬メーカーのディレクトリー

  • メーカーのプロファイルおよび主なサプライヤー

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 810

China's demand for Anti-Obesity Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II.BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Sales Volume
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS

  • Anti-Obesity Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Anti-Obesity Drugs Industry
  • Major Producer Facility Locations and Sales Volume
  • Locations
  • Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Anti-Obesity Drugs by Region
  • Anti-Obesity Drugs Production and Demand
  • Sibutramine
  • Major Manufacturers
  • Supply and Demand
  • Traditional Chinese Medicine
  • Major Manufacturers
  • Supply and Demand
  • Orlistat
  • Major Manufacturers
  • Supply and Demand
  • Rimonabant
  • Major Manufacturers
  • Supply and Demand
  • Metformin
  • Major Manufacturers
  • Supply and Demand
  • Other Anti-Obesity Drugs
  • Anti-Obesity Drugs Imports and Exports
  • Anti-Obesity Drugs Imports
  • Anti-Obesity r Drugs Exports
  • Pricing Trend

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

  • Anti-Obesity Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. ANTI-OBESITY DRUGS PRODUCER DIRECTORY

  • Profiles of Anti-Obesity Drugs Producers and Major Suppliers

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Sales Volume
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. ANTI-OBESITY TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Anti-Obesity Drugs Industry Sales Volume
  • Major Producer Facility Location
  • Major Anti-Obesity Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investment in China

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

  • Anti-Obesity Drugs Production and Demand
  • Demand of Anti-Obesity Drugs by Region
  • Major Sibutramine Producer Sales Volume
  • Sibutramine Drugs Production and Demand
  • Major Traditional Chinese medicine Producer Sales Volume
  • Traditional Chinese Medicine Production and Demand
  • Major Orlistat Producer Sales Volume
  • Olistat Production and Demand
  • Rimonabant Production and Demand
  • Major Metformin Producer Sales Volume
  • Metformin Production and Demand
  • Other Anti-obesity Drugs Production and Demand
  • China Anti-Obesity Drugs Imports and Exports

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

  • Total Anti-Obesity Drugs Sales Volume by Market
  • Consumer Spending Trend
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • China's Anti-Obesity Drugs Sales Volume, Demand

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Sales Volume by Ownership
  • China's Imports and Exports

III. ANTI-OBESITY DRUGS INDUSTRY ASSESSMENTS

  • All kinds of Anti-Obesity Drugs Market Share
  • Anti-Obesity Drugs Sales Volume and Demand

IV. ANTI-OBESITY DRUGS PRODUCTION AND DEMAND

  • Total Anti-Obesity Drugs Production and Demand
  • Total Anti-Obesity Drugs Imports and Exports

V. ANTI-OBESITY DRUGS MARKET OUTLOOK

  • Anti-Obesity Drugs Sales Volume by Market

VI. MARKETING STRATEGIES

  • China's Distribution Channel
Back to Top